Predictive factors for postoperative acute exacerbation of interstitial pneumonia combined with lung cancer

General Thoracic and Cardiovascular Surgery

Volumn 58, Issue 4, 2010, Pages 182-185

  Shintani, Yasushi ^a   Ohta, Mitsunori ^a   Iwasaki, Teruo ^a   Ikeda, Naoki ^a   Tomita, Emiko ^a   Kawahara, Kunimitsu ^b   Ohno, Yuko ^c  

^a OSAKA PREFECTURAL MEDICAL CENTER FOR RESPIRATORY AND ALLERGIC DISEASES   (Japan)

^b OSAKA GENERAL MEDICAL CENTER   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute exacerbation; Lung cancer; Usual interstitial pneumonia

Indexed keywords

C REACTIVE PROTEIN; CARBON MONOXIDE; KRUPPEL LIKE FACTOR 6; LACTATE DEHYDROGENASE;

AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY VOLUME; HISTOPATHOLOGY; HUMAN; INCIDENCE; INTERSTITIAL PNEUMONIA; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; LOBECTOMY; LUNG ALVEOLUS CARBON DIOXIDE TENSION; LUNG ALVEOLUS OXYGEN TENSION; LUNG CANCER; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; LUNG RESECTION; LYMPHOCYTE COUNT; MALE; POSTOPERATIVE COMPLICATION; PREDICTION; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; TOTAL LUNG CAPACITY;

AGED; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INCIDENCE; L-LACTATE DEHYDROGENASE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY SURGICAL PROCEDURES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 77953566571     PISSN: 18636705     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11748-009-0569-z     Document Type: Article

References (17)

1. Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fi brosing alveolitis: a population-based cohort study. Am J Respir Crit Care Med 2000;161:5-8.
2. Kawasaki H, Nagai K, Yokose T, Yoshida J, Nishimura M, Takahashi K, et al. Clinicopathological characteristics of surgically resected lung cancer associated with idiopathic pulmonary fi brosis. J Surg Oncol 2001;76:53-57.
3. Ginsberg RJ, Hill LD, Eagan RT, Thomas P, Mountain CF, Deslauriers J, et al. Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 1983;86:654-658.
4. Wada H, Nakamura T, Nakamoto K, Maeda M, Watanabe Y. Thirty-day operative mortality for thoracotomy in lung cancer. J Thorac Cardiovasc Surg 1998;115:70-73.
5. Ferguson MK, Reeder LB, Mick R. Optimizing selection of patients for major lung resection. J Thorac Cardiovasc Surg 1995;109:275-283.
6. Koizumi K, Hirata T, Hirai K, Mikami I, Okada D, Yamagishi S, et al. Surgical treatment of lung cancer combined with interstitial pneumonia: the effect of surgical approach on post-operative acute exacerbation. Ann Thorac Cardiovasc Surg 2004;10:340-346.
7. Lu KH, Patterson AP, Wang L, Marquez RT, Atkinson EN, Baggerly KA, et al. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res 2004;10:3291-3300.
8. Kumar P, Goldstraw P, Yamada K, Nicholson AG, Wells AU, Hansell DM, et al. Pulmonary fi brosis and lung cancer: risk and benefi t analysis of pulmonary resection. J Thorac Cardiovasc Surg 2003;125:1321-1327.
9. Carrington CB, Gaensler EA, Coutu RE, FitzGerald MX, Gupta RG. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978;298:801-809.
10. Izumi Y, Gika M, Kohno M, Kikuchi K, Kobayashi K. Surgical resection for lung cancer patients with idiopathic interstitial pneumonia. Lung Cancer 1997;18:113-114.
11. DeRemee RA. Serum lactic dehydrogenase activity and diffuse interstitial pneumonitis. JAMA 1968;204:1193-1195.
12. Muraoka M, Tagawa T, Akamine S, Oka T, Tsuchiya T, Araki M, et al. Acute interstitial pneumonia following surgery for primary lung cancer. Eur J Cardiothorac Surg 2006;30:657-662.
13. Ishii H, Mukae H, Kadota J, Kaida H, Nagata T, Abe K, et al. High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specifi c interstitial pneumonia. Thorax 2003;58:121-128.
14. Sakuma T, Takahashi K, Ohya N, Usuda K, Handa M. Serum KL-6, a novel mucin-like glycoprotein, as an indicator of interstitial pneumonitis following lobectomy. Surg Today 1999;29:121-128.
15. Yokoyama A, Kohno N, Hamada H, Sakatani M, Ueda E, Kondo K, et al. Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fi brosis. Am J Respir Crit Care Med 1998;158:1680-1684.
16. Yuksel M, Ozyurtkan MO, Bostanci K, Ahiskari R, Kodalli N. Acute exacerbation of interstitial fi brosis after pulmonary resection. Ann Thorac Surg 2006;82:336-338.
17. Minegishi Y, Takenaka K, Mizutani H, Sudoh J, Noro R, Okano T, et al. Exacerbation of idiopathic interstitial pneumonias associated with lung cancer therapy. Intern Med 2009;48:665-672.